Century Therapeutics, Inc. (IPSC) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Versant Venture Capital VI, L.P. 11,452,014 株保有. その他の主要保有者には Versant Vantage II GP-GP, LLC および Pfeiffenberger Brent.
過去12ヶ月間にインサイダーは 45 件の取引を実施 IPSC 株式 — 17 件の買い (評価額 $3.46M) および 20 件の売り (評価額 $85.18K). インサイダーの売りが買いを上回っています.
IPSC インサイダー保有状況
最大保有者
Versant Venture Capital VI, L.P.
11,452,014 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
11,452,014 |
2022-08-11 |
|
| 2 |
Versant Vantage Ii Gp-gp, Llc |
Director |
11,452,014 |
2022-08-11 |
|
| 3 |
Pfeiffenberger Brent |
President and CEO |
3,710,958 |
2026-03-13 |
|
| 4 |
Cowan Chad |
Chief Scientific Officer |
1,175,680 |
2026-04-03 |
|
| 5 |
Flores Osvaldo |
Chief Executive Officer |
637,500 |
2023-02-06 |
|
| 6 |
Russotti Gregory |
See Remarks |
515,427 |
2026-03-16 |
|
| 7 |
Carr Douglas |
SVP Finance & Operations |
507,261 |
2026-03-16 |
|
| 8 |
Diem Michael Craig |
Chief Financial Officer |
253,533 |
2023-11-03 |
|
| 9 |
Farid Adrienne |
Chief Operations Officer |
250,141 |
2025-06-11 |
|
| 10 |
Lee Han Myung |
Director |
88,000 |
2025-12-11 |
|
| 11 |
Jimenez Joseph |
Director |
44,000 |
2025-06-16 |
|
| 12 |
Carlo Rizzuto |
Director |
44,000 |
2025-06-16 |
|
| 13 |
Riva Alessandro |
Director |
44,000 |
2025-06-16 |
|
| 14 |
Blackwell Kimberly |
Director |
44,000 |
2025-06-16 |
|
| 15 |
Butitta Cynthia M |
Director |
44,000 |
2025-06-16 |
|
| 16 |
Quimi Daphne |
Director |
44,000 |
2025-06-16 |
|
| 17 |
Walbert Timothy P |
Director |
44,000 |
2025-06-16 |
|
| 18 |
Borges Luis |
Chief Scientific Officer |
43,750 |
2023-03-23 |
|
| 19 |
Levitsky Hyam |
President of R&d |
24,000 |
2024-03-11 |
|
| 20 |
Casdin Eli |
Director |
19,872 |
2022-06-10 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-04-01 |
Cowan Chad |
Chief Scientific Officer |
RSU 源泉徴収 |
1,365 |
$2.19 |
$2.99K |
| 2026-03-12 |
Russotti Gregory |
See Remarks |
情報に基づく売り |
10,076 |
$2.55 |
$25.68K |
| 2026-03-12 |
Carr Douglas |
SVP Finance & Operations |
情報に基づく売り |
7,043 |
$2.55 |
$17.95K |
| 2026-03-11 |
Cowan Chad |
Chief Scientific Officer |
RSU 源泉徴収 |
1,431 |
$2.73 |
$3.91K |
| 2026-03-11 |
Pfeiffenberger Brent |
President and CEO |
RSU 源泉徴収 |
55,397 |
$2.73 |
$151.23K |
| 2026-03-09 |
Russotti Gregory |
See Remarks |
情報に基づく売り |
479 |
$2.54 |
$1.21K |
| 2026-03-06 |
Pfeiffenberger Brent |
President and CEO |
RSU 源泉徴収 |
463 |
$2.56 |
$1.19K |
| 2026-02-13 |
Pfeiffenberger Brent |
President and CEO |
RSU 源泉徴収 |
31,172 |
$1.75 |
$54.55K |
| 2026-02-03 |
Carr Douglas |
SVP Finance & Operations |
情報に基づく売り |
323 |
$1.82 |
$588.51 |
| 2026-02-02 |
Cowan Chad |
Chief Scientific Officer |
RSU 付与（制限付株式） |
265,000 |
$1.84 |
$487.6K |
| 2026-02-02 |
Pfeiffenberger Brent |
President and CEO |
RSU 付与（制限付株式） |
945,000 |
$1.84 |
$1.74M |
| 2026-02-02 |
Russotti Gregory |
See Remarks |
RSU 付与（制限付株式） |
265,000 |
$1.84 |
$487.6K |
| 2026-02-02 |
Carr Douglas |
SVP Finance & Operations |
RSU 付与（制限付株式） |
225,000 |
$1.84 |
$414K |
| 2026-01-02 |
Cowan Chad |
Chief Scientific Officer |
RSU 源泉徴収 |
1,611 |
$1.00 |
$1.6K |
| 2025-12-22 |
Cowan Chad |
Chief Scientific Officer |
情報に基づく買い |
58,060 |
$0.85 |
$49.25K |
| 2025-12-12 |
Pfeiffenberger Brent |
President and CEO |
情報に基づく買い |
52,000 |
$0.58 |
$30.35K |
| 2025-12-10 |
Pfeiffenberger Brent |
President and CEO |
RSU 源泉徴収 |
463 |
$0.53 |
$243.54 |
| 2025-12-09 |
Lee Han Myung |
Director |
RSU 付与（制限付株式） |
88,000 |
$0.59 |
$52.1K |
| 2025-12-09 |
Lee Han Myung |
Officer |
不明 |
- |
- |
- |
| 2025-12-08 |
Russotti Gregory |
See Remarks |
情報に基づく売り |
526 |
$0.53 |
$279.83 |
| 2025-12-08 |
Carr Douglas |
SVP Finance & Operations |
情報に基づく売り |
257 |
$0.53 |
$136.72 |
| 2025-11-20 |
Cowan Chad |
Chief Scientific Officer |
情報に基づく売り |
5,462 |
$0.50 |
$2.74K |
| 2025-11-19 |
Pfeiffenberger Brent |
President and CEO |
情報に基づく買い |
35,000 |
$0.50 |
$17.33K |
| 2025-11-17 |
Pfeiffenberger Brent |
President and CEO |
情報に基づく売り |
32,456 |
$0.45 |
$14.74K |
| 2025-11-03 |
Carr Douglas |
SVP Finance & Operations |
情報に基づく売り |
292 |
$0.59 |
$171.11 |
